• Ahmed, A. & Keeffe, E.B. (1999) Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. American Journal of Gastroenterology, 94, 249251.
    Direct Link:
  • Al-Taie, O.H., Mork, H., Gassel, A.M., Wilhelm, M., Weissbrich, B., Scheurlen, M. (1999) Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature. Annals of Hematology, 78, 247249.DOI: 10.1007/s002770050510
  • Cheng, A.L. (1996) Steroid-free chemoteraphy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin’s lymphoma. Blood, 87, 1202.
  • Clark, F.L., Drummond, M.W., Chambers, S., Chapman, B.A., Patton, W.N. (1998) Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma. Annals of Oncology, 9, 385387.DOI: 10.1023/A:1008206519571
  • Hoofnagle, J.H., Dusheiko, G.M., Schafer, D.F., Jones, E.A., Micetich, K.C., Young, R.C., Costa, J. (1982) Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Annals of Internal Medicine, 96, 447449.
  • Honkoop, P., Niestefs, H.G., De Man, R.A., Osterhaus, A.D., Shalm, S.W. (1997) Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. Journal of Hepatology, 26, 13931395.DOI: 10.1016/S0168-8278(97)80476-X
  • Kosaka, Y., Takase, K., Kojima, M., Shmizu, M., Inoue, K., Yoshiba, M., Tanaka S., Akahane, Y., Okamoto, H., Tsuda, F. (1991) Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology, 100, 10871094.
  • Kumagai, K., Takagi, T., Nakamura, S., Sawada, U., Kura, Y., Kodama, F., Shimano, S., Kudoh, I., Nakamura, H., Sawada, K., Ohnoshi, T. (1997) Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan. Annals of Oncology, 8, 107109.
  • Lau, G.K., Liang, R., Wu, P.C., Lee, C.K., Lim, W.L., Au, W.Y. (1998) Use of famciclovir to prevent HBV reactivation in HbsAg positive recipients after allogeneic bone marrow transplantation. Journal of Hepatology, 28, 359368.
  • Liang, R., Lau, G.K., Kwong, Y.L. (1999) Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. Journal of Clinical Oncology, 17, 394398.
  • Lok, A.S., Liang, R.H., Chiu, E.K., Wong, K.L., Chan, T.K., Todd, D. (1991) Reactivation of B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology, 100, 182188.
  • Maguire, C.M., Crawford, D.H., Hourigan, L.F., Clouston, A.D., Walpole, E.T., Powell, E.E. (1999) Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy. Journal of Gastroenterological Hepatology, 14, 801803.
  • Majluf-Cruz, A., Luna-Castanos, G., Trevino perez, S., Santoscoy, M., Nieto-Cisneros, L. (2000) Lamivudine-induced pure red cell aplasia. American Journal of Hematology, 65, 189191.DOI: 10.1002/1096-8652(200011)65:3<189::AID-AJH2>3.0.CO;2-6
  • Markovic, S., Drozina, G., Vovk, M., Fidler-Jenko, M. (1999) Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosoppressive therapy. A prospective study in 305 patients. Hepatogastroenterology, 46, 29252930.
  • Nakamura, Y., Motokura, T., Fujita, A., Yamashita, T., Ogata, E. (1996) Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan. 1987–91. Cancer, 78, 22102215.DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0
  • Niesters, H.G., Honkoop, P., Haagsma, H.B., De Man, R.A., Schalm, S.W., Osterhaus, A.D. (1998) Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. Journal of Infection and Disease, 177, 13821385.
  • Ohtsu, T., Sai, T., Oka, M., Sugai, Y., Tobinai, K. (1991) Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies. Jpn. Journal of Clinical Oncology, 21, 360365.
  • Picardi, M., Selleri, C., De Rosa, G., Raiola, A., Pezzullo, L., Rotoli, B. (1998) Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21, 12671269.
  • Silvestri, F., Ermacora, A., Sperotto, A., Patriarca, F., Zaja, F., Damiani, D., Fanin, R., Baccarani, M. (2000) Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation. British Journal of Haematology, 108, 394396.DOI: 10.1046/j.1365-2141.2000.01847.x
  • Tipples, G.A., Ma, M.M., Fischer, K.P., Bain, V.G., Kpeteman, N.M., Tyrrel, D.L. (1996) Mutation in HBV RNA dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology, 24, 714717.
  • Wong, W.W.S., Ma, M.M., Bain, W.G. (1998) Treatment of immunosuppression-related HBV exacerbation with lamivudine. Hepatology, 28 , Part 2, 725.
  • Yeo, W., Steinberg, J.L., Tam, J.S., Chan, P.K., Leung, N.W., Lam, K.C., Mok, T.S., Johnson, P.J. (1999) Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy. Journal of Medicine Virology, 59, 263269.
  • Yeo, W., Chan, P.K.S., Zhong, S., Ho, W.M., Steimberg, J.L., Tam, J.S., Hui, P., Leung, N.W.Y., Zee, B., Johnson, P.J. (2000) Frequency of hepatitis B virus reactivation in cancer patient undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. Journal of Medical Virology, 62, 299307.DOI: 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0